343 related articles for article (PubMed ID: 9744472)
1. Mutations of the human E-cadherin (CDH1) gene.
Berx G; Becker KF; Höfler H; van Roy F
Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
[TBL] [Abstract][Full Text] [Related]
2. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online.
Becker KF; Reich U; Schott C; Becker I; Berx G; van Roy F; Höfler H
Hum Mutat; 1999; 13(2):171. PubMed ID: 10094558
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
[TBL] [Abstract][Full Text] [Related]
4. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
[TBL] [Abstract][Full Text] [Related]
5. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
Hollestelle A; Elstrodt F; Timmermans M; Sieuwerts AM; Klijn JG; Foekens JA; den Bakker MA; Schutte M
Breast Cancer Res Treat; 2010 Jul; 122(1):125-33. PubMed ID: 19763817
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
[TBL] [Abstract][Full Text] [Related]
8. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.
More H; Humar B; Weber W; Ward R; Christian A; Lintott C; Graziano F; Ruzzo AM; Acosta E; Boman B; Harlan M; Ferreira P; Seruca R; Suriano G; Guilford P
Hum Mutat; 2007 Feb; 28(2):203. PubMed ID: 17221870
[TBL] [Abstract][Full Text] [Related]
9. [Germline E-cadherin gene mutation screening in familial gastric cancer kindreds].
Jiang Y; Wan YL; Wang ZJ; Zhao B; Zhu J; Huang YT
Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):914-7. PubMed ID: 15363252
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
[TBL] [Abstract][Full Text] [Related]
11. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management.
Corso G; Roviello F; Paredes J; Pedrazzani C; Novais M; Correia J; Marrelli D; Cirnes L; Seruca R; Oliveira C; Suriano G
Eur J Surg Oncol; 2007 Nov; 33(9):1061-7. PubMed ID: 17434710
[TBL] [Abstract][Full Text] [Related]
13. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
Humar B; Toro T; Graziano F; Müller H; Dobbie Z; Kwang-Yang H; Eng C; Hampel H; Gilbert D; Winship I; Parry S; Ward R; Findlay M; Christian A; Tucker M; Tucker K; Merriman T; Guilford P
Hum Mutat; 2002 May; 19(5):518-25. PubMed ID: 11968084
[TBL] [Abstract][Full Text] [Related]
14. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
15. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies.
Becker KF; Kremmer E; Eulitz M; Schulz S; Mages J; Handschuh G; Wheelock MJ; Cleton-Jansen AM; Höfler H; Becker I
J Pathol; 2002 Aug; 197(5):567-74. PubMed ID: 12210074
[TBL] [Abstract][Full Text] [Related]
16. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
17. Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis.
Mărgineanu E; Cotrutz CE; Cotrutz C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):432-6. PubMed ID: 19295016
[TBL] [Abstract][Full Text] [Related]
18. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer.
Stone J; Bevan S; Cunningham D; Hill A; Rahman N; Peto J; Marossy A; Houlston RS
Br J Cancer; 1999 Apr; 79(11-12):1935-7. PubMed ID: 10206317
[TBL] [Abstract][Full Text] [Related]
20. [Novel mutation-specific monoclonal E-cadherin antibodies make possible allele differentiation at the protein level in tumors].
Becker I; Becker KF; Kremmer E; Eulitz M; Handschuh G; Höfler H
Verh Dtsch Ges Pathol; 1999; 83():233-9. PubMed ID: 10714216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
